Executive Summary Mounjaro, a diabetes and weight-loss injection that reached India only in 2025, is now the country’s best-selling brand, with ₹923 crore in sales in the 12 months to Marc...
Dr. Reddy’s Signs License Deal for Once-Yearly Lenacapavir The Story:Dr. Reddy’s has signed a royalty-free, non-exclusive license agreement with Gilead Sciences for investigational once-yearly lenacap...
Key Highlights: Implications: Alkem’s launch of NeuCeno (cenobamate) introduces India’s first cenobamate-based anti‑seizure medication for adults with partial‑onset seizures, adding a high...
Summary: The Top 10 Indian Pharmaceutical Companies of 2026 demonstrate the continued strength and global competitiveness of India’s pharmaceutical sector, led by Sun Pharmaceutical Industries, ...
Key Highlights: Implications: By pricing its once‑weekly semaglutide at around ₹450 per week via a pre‑filled disposable pen, Alkem is positioning one of the lowest‑cost GLP‑1 op...
